Edition:
United Kingdom

Brainstorm Cell Therapeutics Inc (BCLI.OQ)

BCLI.OQ on NASDAQ Stock Exchange Capital Market

3.93USD
25 Jun 2019
Change (% chg)

$-0.08 (-2.00%)
Prev Close
$4.01
Open
$3.93
Day's High
$3.93
Day's Low
$3.93
Volume
11,693
Avg. Vol
12,890
52-wk High
$4.44
52-wk Low
$2.95

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.240
FY 2018 Dec '18 0.00 -0.260
Sep '18 0.00 -0.153
Jun '18 0.00 -0.158
Mar '18 0.00 -0.121
FY 2017 Dec '17 0.00 0.015
Sep '17 0.00 -0.128
Jun '17 0.00 -0.056
Mar '17 0.00 -0.096
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 1 0.00 0.00 0.00 1.50
Quarter Ending Sep-19 1 0.00 0.00 0.00 1.50
Year Ending Dec-19 1 0.00 0.00 0.00 6.00
Year Ending Dec-20 2 49.25 98.50 0.00 94.60
Earnings (per share)
Quarter Ending Jun-19 1 -0.24 -0.24 -0.24 -0.11
Quarter Ending Sep-19 1 -0.18 -0.18 -0.18 -0.11
Year Ending Dec-19 2 -0.76 -0.70 -0.82 -0.64
Year Ending Dec-20 2 -0.87 -0.85 -0.89 -0.32
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.29 32.55
P/E High - Last 5 Yrs. -- 147.69 48.11
P/E Low - Last 5 Yrs. -- 47.94 23.41
Beta 1.54 1.08 0.87
Price to Sales (TTM) -- 49.50 8.44
Price to Book (MRQ) 10.34 10.13 5.27
Price to Tangible Book (MRQ) 10.39 13.74 6.74
Price to Cash Flow (TTM) -- 56.16 24.12
% Owned Institutions 12.71 3.72 1.65

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.37
Dividend 5 Year Growth Rate -- 0.78 4.71
Payout Ratio(TTM) -- 7.02 39.59

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 206.03 13.45
Sales (TTM) vs TTM 1 Yr. Ago -- 49.04 8.04
Sales - 5 Yr. Growth Rate -- 22.77 10.84
EPS (MRQ) vs Qtr. 1 Yr. Ago -7.62 75.31 48.19
EPS (TTM) vs TTM 1 Yr. Ago 25.48 -- --
EPS - 5 Yr. Growth Rate -- 11.97 10.46
Capital Spending - 5 Yr. Growth Rate 16.50 9.11 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.18
Current Ratio (MRQ) 10.80 3.57 2.98
LT Debt to Equity (MRQ) 0.00 18.62 11.35
Total Debt to Equity (MRQ) 0.00 31.29 16.04
Interest Coverage (TTM) -- -43.11 28.45

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.28 52.36
Gross Margin - 5 Yr. Avg. -- 60.50 50.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.91 12.41
Operating Margin (TTM) -- -184.92 5.62
Operating Margin - 5 Yr. Avg. -- -127.40 8.00
Pre-Tax Margin (TTM) -- -175.61 4.64
Pre-Tax Margin - 5 Yr. Avg. -- -133.19 8.28
Net Profit Margin (TTM) -- -182.33 1.37
Net Profit Margin - 5 Yr. Avg. -- -137.59 4.69
Effective Tax Rate (TTM) -- 22.46 22.13
Effective Tax Rate - 5 Yr. Avg. -- 15.50 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,652,641 819,624,671
Net Income/Employee (TTM) -- 513,407 92,776,869
Receivable Turnover (TTM) -- 6.28 5.82
Inventory Turnover (TTM) -- 1.89 3.42
Asset Turnover (TTM) 0.00 0.32 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -47.79 6.37 10.65
Return on Assets - 5 Yr. Avg. -71.19 5.47 11.77
Return on Investment (TTM) -52.76 8.90 13.82
Return on Investment - 5 Yr. Avg. -91.15 6.78 15.32
Return on Equity (TTM) -52.76 10.04 15.24
Return on Equity - 5 Yr. Avg. -93.46 8.36 16.41
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 42.12 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Brainstorm Cell Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -5.41 -8.67 23 99
13 Week -10.67 -15.02 32 95
26 Week 0.25 -7.37 54 97
52 Week 66.12 40.80 82 70
YTD 58.27 38.99 78 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 11.40%
# of Holders: 42
Total Shares Held: 2,473,180
3 Mo. Net Change: -77,310
# New Positions: 4
# Closed Positions: 3
# Increased Positions: 18
# Reduced Positions: 7
# Net Buyers: 11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.